Jon Blatchford
Impact in
-
- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Cardiac Valve Diseases and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Heart Failure Treatment and Management 12
- Atrial Fibrillation Management and Outcomes 2
- Blood Pressure and Hypertension Studies 1
-
- Diabetes Treatment and Management 2
- Co-authors
- Martina Brueckmann (11 shared papers)Frans Van de Werf (1 shared paper)Ruth Harper (1 shared paper)Maarten L. Simoons (1 shared paper)John W. Eikelboom (1 shared paper)Maximilian T. Lobmeyer (1 shared paper)Michael J. Mack (1 shared paper)Hugo J. Maas (1 shared paper)
- Journals
- European Journal of Heart Failure (6 papers)Stroke (2 papers)International Journal of Pharmacy Practice (1 paper)Allergy and Asthma Proceedings (1 paper)Nature Medicine (1 paper)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Jon Blatchford
21 papers receiving 2.4k citations
Jon Blatchford's Hit Papers
Peers
Comparison fields: 5 of 70
- Cardiology and Cardiovascular Medicine 1.8k
- Internal Medicine 171
- Endocrinology, Diabetes and Metabolism 347
- Hematology 90
- Neurology 77
Countries citing papers authored by Jon Blatchford
This map shows the geographic impact of Jon Blatchford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Blatchford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Blatchford more than expected).
Fields of papers citing papers by Jon Blatchford
This network shows the impact of papers produced by Jon Blatchford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Blatchford. The network helps show where Jon Blatchford may publish in the future.
Co-authors
The 25 scholars most cited alongside Jon Blatchford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dabigatran versus Warfarin in Patients with Mechanical Heart Valves Hit paper breakdown → | 2013 | 1134 |
| 2 | The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial Hit paper breakdown → | 2022 | 679 |
| 3 | Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial Hit paper breakdown → | 2022 | 168 |
| 4 | 2022 | 113 | |
| 5 | 2021 | 73 | |
| 6 | Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies. | 2010 | 71 |
| 7 | 2012 | 70 | |
| 8 | 2016 | 60 | |
| 9 | 2022 | 40 | |
| 10 | 2023 | 35 | |
| 11 | 2017 | 25 | |
| 12 | 2012 | 18 | |
| 13 | 2024 | 16 | |
| 14 | 2023 | 11 | |
| 15 | 2017 | 10 | |
| 16 | 2022 | 5 | |
| 17 | 2024 | 4 | |
| 18 | 2024 | 2 | |
| 19 | 2019 | 1 | |
| 20 | 2023 | 1 |
About Jon Blatchford
Jon Blatchford is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Geriatrics and Gerontology, Toxicology and Physiology, having authored 21 papers that have together received 2.5k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (12 papers), Atrial Fibrillation Management and Outcomes (2 papers), Asthma and respiratory diseases (2 papers), Diabetes Treatment and Management (2 papers), Acute Ischemic Stroke Management (1 paper), Blood Pressure and Hypertension Studies (1 paper), Pharmaceutical Practices and Patient Outcomes (1 paper) and Cerebrovascular and genetic disorders (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.8k citations), Internal Medicine (171 citations), Endocrinology, Diabetes and Metabolism (347 citations), Hematology (90 citations) and Neurology (77 citations). Jon Blatchford has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Martina Brueckmann, Frans Van de Werf, Ruth Harper, Maarten L. Simoons, John W. Eikelboom, Maximilian T. Lobmeyer, Michael J. Mack, Hugo J. Maas, A. Pieter Kappetein and Yasser Khder. Their work appears in journals such as European Journal of Heart Failure, Stroke, International Journal of Pharmacy Practice, Allergy and Asthma Proceedings and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.